Abstract:Mucosa-associated biofilms are associated with many human disease states, but the host mechanisms promoting biofilm remain unclear. In chronic respiratory diseases like cystic fibrosis (CF), Pseudomonas aeruginosa establishes chronic infection through biofilm formation. P . aeruginosa can be attracted to interspecies biofilms through potassium currents emanating from the biofilms. We hypothesized that P . aeruginosa could, similarly, sense and respond to the potassium efflux from human airway epithelial cells (AECs) to promote biofilm. Using respiratory epithelial co-culture biofilm imaging assays of P . aeruginosa grown in association with CF bronchial epithelial cells (CFBE41o - ), we found that P . aeruginosa biofilm was increased by potassium efflux from AECs, as examined by potentiating large conductance potassium channel, BK Ca (NS19504) potassium efflux. This phenotype is driven by increased bacterial attachment and increased coalescence of bacteria into aggregates. Conversely, biofilm formation was reduced when AECs were treated with a BK Ca blocker (paxilline). Using an agar-based macroscopic chemotaxis assay, we determined that P . aeruginosa chemotaxes toward potassium and screened transposon mutants to discover that disruption of the high-sensitivity potassium transporter, KdpFABC, and the two-component potassium sensing system, KdpDE, reduces P . aeruginosa potassium chemotaxis. In respiratory epithelial co-culture biofilm imaging assays, a KdpFABCDE deficient P . aeruginosa strain demonstrated reduced biofilm growth in association with AECs while maintaining biofilm formation on abiotic surfaces. Furthermore, we determined that the Kdp operon is expressed in vivo in people with CF and the genes are conserved in CF isolates. Collectively, these data suggest that P . aeruginosa biofilm formation can be increased by attracting bacteria to the mucosal surface and enhancing coalescence into microcolonies through aberrant AEC potassium efflux sensed by the KdpFABCDE system. These findings suggest host electrochemical signaling can enhance biofilm, a novel host-pathogen interaction, and potassium flux could be a therapeutic target to prevent chronic infections in diseases with mucosa-associated biofilms, like CF. Biofilm formation is important for Pseudomonas aeruginosa to cause chronic infections on epithelial surfaces during respiratory diseases, like cystic fibrosis (CF). The host factors that promote biofilm formation on host surfaces are not yet fully understood. Potassium signals from biofilms can attract P . aeruginosa , but it is unknown if potassium from the human cells can influence P . aeruginosa biofilm formation on a host surface. We found that P . aeruginosa biofilm formation on human airway cells can be increased by the potassium currents from airway cells. Furthermore, we determined bacterial genes related to potassium uptake and sensing that contribute to biofilm formation on airway cells, which are expressed in humans during infection. These findings suggest that P . aeruginosa can respond to host potassium signals by forming increased biofilm and that reducing chronic infections may be accomplished by reducing potassium coming from airway cells or blocking the bacterial proteins responsible for the biofilm enhancement by potassium currents.

The opportunistic pathogen Pseudomonas aeruginosa exploits bacterial biotin synthesis pathway to benefit its infectivity

Metabolic pathways of Pseudomonas aeruginosa involved in competition with respiratory bacterial pathogens

Pec 1 of Pseudomonas aeruginosa Inhibits Bacterial Clearance of Host by Blocking Autophagy in Macrophages

Pseudomonas aeruginosa cytochrome P450 CYP168A1 is a fatty acid hydroxylase that metabolizes arachidonic acid to the vasodilator 19-HETE

Pseudomonas aeruginosa essential gene perturbations that confer vulnerability to the mammalian host environment

Metabolic Mechanism and Physiological Role of Glycerol 3-Phosphate in Pseudomonas aeruginosa PAO1

PBP Target Profiling by β-Lactam and β-Lactamase Inhibitors in Intact Pseudomonas aeruginosa: Effects of the Intrinsic and Acquired Resistance Determinants on the Periplasmic Drug Availability

The Type III Secretion System Facilitates Systemic Infections of Pseudomonas Aeruginosa in the Clinic.

Pseudomonas aeruginosa senses and responds to epithelial potassium flux via Kdp operon to promote biofilm

Pseudomonas aeruginosa transcriptome adaptations from colonization to biofilm infection of skin wounds

Peroxisome proliferator-activated receptor-γ agonists attenuate biofilm formation by Pseudomonas aeruginosa

Mycobacterial biotin synthases require an auxiliary protein to convert dethiobiotin into biotin

Three enigmatic BioH isoenzymes are programmed in the early stage of mycobacterial biotin synthesis, an attractive anti-TB drug target

A putative lipase affects Pseudomonas aeruginosa biofilm matrix production

Pathogenesis in Pseudomonas aeruginosa PAO1 Biofilm-Associated Is Dependent on the Pyoverdine and Pyocyanin Siderophores by Quorum Sensing Modulation

Reconstruction of the metabolic network of Pseudomonas aeruginosa to interrogate virulence factor synthesis

Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa

Pseudomonas aeruginosa kills Staphylococcus aureus in a polyphosphate-dependent manner

The diadenosine tetraphosphate hydrolase ApaH contributes to Pseudomonas aeruginosa pathogenicity

Characterization of acquired β-lactamases in Pseudomonas aeruginosa and quantification of their contributions to resistance

Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant <i>Pseudomonas aeruginosa</i>